STIPULATION AND ORDER OF DISMISSAL. IT IS HEREBY STIPULATED AND AGREED, by and between the undersigned, the attorneys of record for all the patties to the above-entitled action, pursuant to the Florida Rules of Civil Procedure, that whereas no xxxxx hereto is an infant or incompetent person for whom a committee has been appointed or conservatee and no person not a pany has an interest in the subject matter of the action, the above-entitled action be, and the same hereby is, dismissed, each xxxxx to beat its own costs. Dated: , 2016. Xxxxxxx X. Xxxxxxx, Xx., Esq. Xxxxxxx X. Xxxxx, Esquire XXXXXXX X. XXXXXXX, XX., P.A. P.O. Box 19702 Satasota, Florida 00000 000-000-0000 (phone) 000-000-0000 (fax) Florida Bar Xx. 0000000 Xxxxxxx Xxx Xx. 0000000 2127 Ringling Blvd., Suite I 04 Sarasota, Florida 00000 (000) 000-0000 phone (000) 000-0000 facsimile Attorney for Defendant Attorney for Plaintiff SO ORDERED: The Honorable SCHEDULE A CLAIMS Company Nature of Claim Payment to be paid within ten (10) day after Court order granting approval of settlement agreement pursuant to Claims Purchase Agreements annex hereto Payment to be paid within thirty (30) days which could be triggered by a default event after Court Order granting approval of settlement agreement pursuant to Claims Purchase Agreements annexed hereto Total Debt Purchase Xxx Xxxxxx Invoice $ 5,181.25 $ 5,181.25 $ 10,362.50 Xxxxxxxx & CO. Invoice $ 6,750.00 $ 6,750.00 $ 13,500.00 Presidents Stock Transfer Invoice $ 4,024.25 $ 4,024.25 $ 8,048.50 SD Xxxxxxxx & Associates, PLC Invoice $ 5,000.00 $ 5,000.00 $ 10,000.00 Ideal Connection Invoice $ 2,376.06 $ 2,376.06 $ 4,752.13 Channel Sales and Consulting Invoice $ 10,144.50 $ 10,144.50 $ 20,289.00 PAG Group Invoice $ 5,000.00 $ 5,000.00 $ 10,000.00 Xxxxxx Associates, L.P. Invoice $ 2,500.00 $ 2,500.00 $ 5,000.00 Totals $ 40,976.06 $ 40,976.06 $ 81,952.13
STIPULATION AND ORDER OF DISMISSAL. Pursuant to Rule 41(a)(1) of the Federal Rules of Civil Procedure, it is hereby stipulated by and between plaintiff, PDL BioPharma, Inc., and defendant, Alexion Pharmaceuticals, Inc., that this action, including all claims and counterclaims, be and hereby is dismissed in its entirety with prejudice effective December 31, 2008, subject to the terms and conditions of the Settlement Agreement and the Patent License Agreement, each dated December 31, 2008. Each party shall bear its own costs, expenses and attorneys fees. [*] = Portions of this exhibit have been omitted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Commission. XXXXXX, XXXXXXX, ARSHT & XXXXXXX LLP YOUNG, CONAWAY, STARGATT & XXXXXX, LLP Xxxx X. Xxxxxxxxxx (#1014) Xxxxx Xxxxxx Xxxxxx (#2881) 0000 Xxxxx Xxxxxx Xxxxxx P.O. Box 1347 Wilmington, DE 19899-1347 (000) 000-0000 xxxxxxxxxxx@xxxx.xxx xxxxxxx@xxxx.xxx Xxxx X. Xxxxxxxxx (#1088) Xxxx X. Xxxx (#3362) Xxxxxx X. Xxxxxxxx (#4429) The Brandywine Building 0000 Xxxx Xxxxxx, 00xx Xxxxx P.O. Box 391 Wilmington, DE 19801 xxxxxxxxxx@xxxx.xxx xxxxx@xxxx.xxx xxxxxxxxx@xxxx.xxx Attorneys for Plaintiff PDL BioPharma, Inc. Attorneys for Defendant Alexion Pharmaceuticals, Inc. SO ORDERED this day of , 2009. Xxxxxxxxx Xxxxxx X. Farnan, Jr. [*] = Portions of this exhibit have been omitted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Commission. Stipulated Joint Stay IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE ) PDL BIOPHARMA, INC., ) ) Plaintiff, ) )
STIPULATION AND ORDER OF DISMISSAL. Within three (3) business days of the Parties’ execution of this Agreement, the Parties shall file a Joint Stipulation for Dismissal with Prejudice, attached to this Agreement as Exhibit “A”, of all claims and counterclaims, excepting only the enforcement of this Agreement, the Parties now have or may have in the future with respect to the Litigation. The Joint Stipulation for Dismissal with Prejudice shall include that each party shall bear its own attorney’s fees and costs and that the Court will retain jurisdiction to enforce this Agreement.
STIPULATION AND ORDER OF DISMISSAL. The Parties agree that they will execute and file a stipulation and order of dismissal within five business days following the Court’s full and final approval regarding this matter which may include, but is not limited to, a report regarding settlement distribution.
STIPULATION AND ORDER OF DISMISSAL. XXXX INNOVATIONS INCORPORATED, and Does 1-10, Defendants. Date: * XXXX INNOVATIONS INCORPORATED, Time: * Dept: 8C (Complex Civil Litigation) Cross-Complainant, Xxx. Xxxxxx X. Huber
STIPULATION AND ORDER OF DISMISSAL. The Parties shall cooperate with each other in obtaining dismissal with prejudice with NTOG in regards to the Litigation.
STIPULATION AND ORDER OF DISMISSAL. In consideration of the mutual benefits of entering into this Agreement, the Parties shall enter into and cause to be filed with the Court, within *** of the Effective Date, a stipulation and order of dismissal substantially in the form annexed hereto as Exhibit A (the “Stipulation and Execution Copy Confidential Order of Dismissal”). If the Court does not grant the Stipulation and Order of Dismissal substantially in the form annexed hereto as Exhibit A, the Parties agree to confer in good faith and revise that document consistent with the terms of this Agreement and the License Agreement and the requirements of the Court.
STIPULATION AND ORDER OF DISMISSAL. Pursuant to Federal Rules of Civil Procedure 41(a)(1)(A)(ii) and 41(c), and by agreement between Plaintiff Vivus, Inc. (“Vivus”) and Defendant Actavis Laboratories FL, Inc. (“Actavis,” and together with Vivus, the “Parties”), the Parties hereby stipulate and agree that all claims, counterclaims and affirmative defenses asserted by the Parties against each other in the above-captioned action (the “Action”) are hereby dismissed without prejudice and without costs, disbursements, or attorneys’ fees to any party. It is further stipulated that the U.S. District Court for the District of New Jersey retains jurisdiction to enforce and resolve any disputes related to the Parties’ resolution of the Action. Execution Copy Confidential
STIPULATION AND ORDER OF DISMISSAL. Whereas Plaintiff Medicis Pharmaceutical Corporation (“Medicis”) brought this action asserting infringement of United States Patent Nos. 6,765,001, 7,220,424 and 7,217,422 (the “Medicis Patents”); Whereas Taro Pharmaceutical U.S.A., Inc. submitted to the U.S. Food and Drug Administration Abbreviated New Drug Application (“ANDA”) No. 20-734 (the “Taro ANDA) seeking approval to market and sell a generic fluocinonide cream USP, 0.1%, (the “Taro Product”); Whereas Taro Pharmaceutical U.S.A., Inc. and Taro Pharmaceutical Industries, Ltd. (collectively “Taro”) and Medicis are parties to litigation in this Court and the United States District Court for the Southern District of New York relating to the Taro ANDA and the Medicis Patents, before the expiration of the Medicis Patents (the “Litigations”);
STIPULATION AND ORDER OF DISMISSAL. At the Closing, the Parties shall stipulate to an Order of Dismissal of the Litigation, with prejudice, including all claims and counterclaims. The funds previously paid by EEZ to STTX under protest shall be released to and vest in STTX and the protest shall be vacated.
